Centene Reports Q4 2024 Profit of $283 Million, Adjusted EPS of $0.80 and Sales of $40.80B Beat Estimates

Centene Corporation reported fourth-quarter 2024 results that exceeded Wall Street expectations, with an adjusted earnings per share (EPS) of $0.80, surpassing the estimate of $0.49. The company generated sales of $40.80 billion, which also beat the anticipated $39.13 billion. Centene's profit for the quarter was $283 million, attributed to lower medical costs. This performance indicates a strong financial position for the company as it navigates the healthcare market.